Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test is usually 5-7 business days.

What are the prerequisites for the test Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test

  • Preparation: No fasting or special preparations are required for this test
  • Sample Required: Blood sample
  • Collection Method: Venipuncture
  • Other Requirements: None

What are the measure values for the test Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test

Measure Value
Reference Range Less than 0.02 nmol/L
Indeterminate Range 0.02 - 0.05 nmol/L
Positive Range Greater than 0.05 nmol/L

What does this test Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test identify?

Test: Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test

Test: Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test

This test identifies the presence of antibodies against Glutamate Decarboxylase 65 (GAD 65) in the blood. GAD 65 is an enzyme involved in the synthesis of the neurotransmitter gamma-aminobutyric acid (GABA). Antibodies against GAD 65 are associated with certain neurological disorders, such as stiff person syndrome, cerebellar ataxia, and autoimmune encephalitis.

Why is this test Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test taken?

  1. Diagnosis of Paraneoplastic Syndrome:

    The Glutamate Decarboxylase 65 (GAD 65) Antibody Paraneoplastic Syndrome Test is taken to help diagnose paraneoplastic syndrome. Paraneoplastic syndromes are rare disorders that are triggered by an abnormal immune response to cancer cells in the body. These syndromes can affect various organs and tissues, leading to a range of symptoms.

  2. Identification of Autoimmune Response:

    GAD 65 antibodies are produced by the immune system in response to the presence of cancer cells in the body. By testing for these antibodies, healthcare providers can identify the presence of an autoimmune response that may be associated with paraneoplastic syndrome.

  3. Monitoring Treatment Response:

    In some cases, the GAD 65 Antibody Paraneoplastic Syndrome Test may be used to monitor the effectiveness of treatment for paraneoplastic syndrome. By tracking changes in antibody levels over time, healthcare providers can assess the response to therapy and make adjustments as needed.

No FAQs available.

Customer Google Rating